Schisandrol A Suppresses Catabolic Factor Expression by Blocking NF-κB Signaling in Osteoarthritis

• Autori principali: Seong Jae Han (Autore), Jimoon Jun (Autore), Seong-il Eyun (Autore), Choong-Gu Lee (Autore), Jimin Jeon (Autore), Cheol-Ho Pan (Autore)
• Natura: Libro
• Pubblicazione: MDPI AG, 2021-03-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Schisandrol A possesses pharmacological properties and is used to treat various diseases; however, its effects on osteoarthritis (OA) progression remain unclear. Here, we investigated Schisandrol A as a potential therapeutic agent for OA. In vitro, Schisandrol A effects were confirmed based on the l...